Literature DB >> 14979438

Antibody response in sows and piglets following vaccination against Mycoplasma hyopneumoniae, toxigenic Pasteurella multocida, and Actinobacillus pleuropneumoniae.

Charlotte S Kristensen1, Margit Andreasen, Annette K Ersbøll, Jens P Nielsen.   

Abstract

The aim of the experimental study was to compare the humoral immune response and occurrence of adverse effects following single or multiple simultaneous vaccination of sows against Mycoplasma hyopneumonia, toxigenic Pasteurella multocida, and Actinobacillus pleuropneumoniae. In addition, passively transferred antibodies to piglets were studied until weaning at 3 weeks of age. Fever was seen in a few sows within the first 12 hours after the 1st and 2nd vaccination. No difference in the occurrence of other adverse effects was observed between groups. Antibody levels were significantly higher in vaccinated sows and their offspring compared with the control group. This was found to be independent of single or simultaneous vaccinations with the 3 vaccines. In conclusion, applying multiple vaccines simultaneously to sows appeared not to influence the occurrence of adverse effects or the sow's serum levels of antibodies at the time of farrowing, nor the offspring's serum levels up to 3 weeks of age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14979438      PMCID: PMC1142132     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  7 in total

1.  Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae.

Authors:  R Nielsen; J F van den Bosch; T Plambeck; V Sørensen; J P Nielsen
Journal:  Vet Microbiol       Date:  2000-01       Impact factor: 3.293

2.  A monoclonal blocking ELISA detecting serum antibodies to Mycoplasma hyopneumoniae.

Authors:  N C Feld; P Qvist; P Ahrens; N F Friis; A Meyling
Journal:  Vet Microbiol       Date:  1992-01       Impact factor: 3.293

3.  Vaccine efficacy for reducing turbinate atrophy and improving growth rate in piggeries with endemic atrophic rhinitis.

Authors:  M J Kabay; A R Mercy; J M Lloyd; G M Robertson
Journal:  Aust Vet J       Date:  1992-05       Impact factor: 1.281

4.  The Mycoplasma hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia.

Authors:  M Kobisch; L Quillien; J P Tillon; H Wróblewski
Journal:  Ann Inst Pasteur Immunol       Date:  1987 Sep-Oct

5.  An on-farm study of the epidemiology of Actinobacillus pleuropneumoniae infection in pigs as part of a vaccine efficacy trial.

Authors:  S Wongnarkpet; D U Pfeiffer; R S Morris; S G Fenwick
Journal:  Prev Vet Med       Date:  1999-03-12       Impact factor: 2.670

6.  Blocking enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serotype 2.

Authors:  R Nielsen; T Plambeck; N T Foged
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

7.  Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies.

Authors:  N T Foged; J P Nielsen; S E Jorsal
Journal:  Vet Rec       Date:  1989-07-01       Impact factor: 2.695

  7 in total
  2 in total

1.  Comparative studies for serodiagnosis of haemorrhagic septicaemia in cattle sera.

Authors:  Jakeen K El-Jakee; Samah Said Ali; Soumaya Ahmed El-Shafii; Ashgan M Hessain; Abdullah A Al-Arfaj; Moussa I Mohamed
Journal:  Saudi J Biol Sci       Date:  2015-06-16       Impact factor: 4.219

Review 2.  Impact of maternally derived immunity on immune responses elicited by piglet early vaccination against the most common pathogens involved in porcine respiratory disease complex.

Authors:  Núria Martínez-Boixaderas; Laura Garza-Moreno; Marina Sibila; Joaquim Segalés
Journal:  Porcine Health Manag       Date:  2022-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.